相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity
Olavo Vicente Neto et al.
CLINICAL BIOCHEMISTRY (2018)
Clinical Translation of the National Institutes of Health's Investments in Nanodrug Products and Devices
Lori A. Henderson et al.
AAPS JOURNAL (2017)
Control of Liposomal Penetration into Three-Dimensional Multicellular Tumor Spheroids by Modulating Liposomal Membrane Rigidity
Yuki Takechi-Haraya et al.
MOLECULAR PHARMACEUTICS (2017)
In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil
Angelique Virgone-Carlotta et al.
PLOS ONE (2017)
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy
Maria Stella Sasso et al.
BIOMATERIALS (2016)
Therapeutic drug monitoring of 5-fluorouracil
James J. Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
Peter P. Wibroe et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics
Melani A. Solomon et al.
JOURNAL OF LIPOSOME RESEARCH (2016)
Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma
Stephan Grabbe et al.
NANOMEDICINE (2016)
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
Edward A. Sykes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
Minmin Zhang et al.
ONCOTARGETS AND THERAPY (2016)
5-Fluorouracil derivatives: a patent review (2012-2014)
Esmeralda Carrillo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma
Giovanna Lollo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative
Giovanna Lollo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Characterization and Evaluation of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles Prepared via a Temperature-Modulated Solidification Technique
Meghavi N. Patel et al.
AAPS PHARMSCITECH (2014)
5-Fluorouracil-lipid conjugate: Potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles
N. Ashwanikumar et al.
ACTA BIOMATERIALIA (2014)
An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure
Elodie Moysan et al.
SOFT MATTER (2014)
In Vitro and In Vivo Evaluation of Lipofufol, a New Triple Stealth Liposomal Formulation of Modulated 5-Fu: Impact on Efficacy and Toxicity
Raphaelle Fanciullino et al.
PHARMACEUTICAL RESEARCH (2013)
5-Fluorouracil derivatives: a patent review
Pablo Alvarez et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT Assay
Wan Yong Ho et al.
PLOS ONE (2012)
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
Patrice Cellier et al.
BMC CANCER (2011)
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity
Chen Guang Yang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Therapeutic targeting of myeloid-derived suppressor cells
Stefano Ugel et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer
M. Gusella et al.
ANNALS OF ONCOLOGY (2006)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
A novel phase inversion-based process for the preparation of lipid nanocarriers
B Heurtault et al.
PHARMACEUTICAL RESEARCH (2002)
Synthesis and release of 5-fluorouracil from poly (N-vinylpyrrolidinone) bearing 5-fluorouracil derivatives
ZF Liu et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Anti-cancer drug diffusion within living rat brain tissue:: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres
VG Roullin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2002)
Synthesis of allyloxycarbonyloxymethyl-5-fluorouracil and copolymerizations with N-vinylpyrrolidinone
ZF Liu et al.
JOURNAL OF MATERIALS CHEMISTRY (2000)
分享论文
